LifeStance Health Group (LFST) Stock Price
LifeStance Health Group Price
Revenue has compounded at 37.3% per year over the past 6 years to 1.42 B USD. LifeStance Health Group's net margin stands at 0.7%, up from -46.0% several years earlier. Analysts set a median price target of 13.00 USD, implying 5.4% above the current price. Of 18 analysts, 14 rate the stock a buy — an overall Buy consensus.
LifeStance Health Group stock price
LifeStance Health Group business model & stock analysis
Frequently asked questions about LifeStance Health Group
Lifestance Health Group Inc is a leading healthcare organization specializing in providing comprehensive mental health services. Their business model encompasses the integration of psychiatrists, clinical psychologists, therapists, and psychiatric nurse practitioners to offer personalized and evidence-based treatment to individuals of all ages. By combining a multidisciplinary approach with innovative technologies, Lifestance Health Group Inc aims to deliver high-quality and accessible mental healthcare across their network of clinics. With a focus on patient-centric care and a commitment to improving mental wellness, Lifestance Health Group Inc has become a trusted provider in the industry, striving to make a positive impact on individuals' lives.
Lifestance Health Group Inc is primarily active in the healthcare industry.
The main competitors of Lifestance Health Group Inc in the market include companies such as Acadia Healthcare Company Inc, Universal Health Services Inc, and HCA Healthcare Inc.
Lifestance Health Group Inc is a leading provider of mental health services in the United States. Founded in 2005, the company has a rich history of offering comprehensive and personalized care to individuals struggling with mental health conditions. Lifestance Health Group Inc has established itself as a trusted name in the industry by combining evidence-based practices with a patient-centered approach. With a team of experienced and compassionate clinicians, the company offers a wide range of services, including therapy, medication management, and telepsychiatry. Lifestance Health Group Inc continues to grow and expand its reach to help improve the lives of individuals facing mental health challenges.
Lifestance Health Group Inc has achieved several significant milestones in its journey. The company has successfully expanded its network, establishing a strong presence across multiple states in the United States. Lifestance Health Group Inc has also developed a reputation for excellence in its specialized behavioral health services, offering comprehensive care to patients. The company has consistently grown its patient base, delivering high-quality care and demonstrating exceptional clinical outcomes. Lifestance Health Group Inc has continually focused on innovation, leveraging technology to improve patient experience and streamline operations. Overall, Lifestance Health Group Inc has exhibited impressive growth and success in the behavioral health industry, solidifying its position as a leading provider.
Lifestance Health Group Inc is primarily present in the United States.
Lifestance Health Group Inc represents a strong commitment to providing high-quality mental health care services. The company prides itself on its patient-centered approach, putting individuals at the forefront of their treatment plans. Lifestance Health Group Inc believes in promoting the overall well-being of their patients by offering personalized and evidence-based treatment options. The company's corporate philosophy revolves around creating a supportive and compassionate environment, fostering growth and resilience for their patients. By emphasizing collaboration and innovation, Lifestance Health Group Inc ensures that individuals receive comprehensive care that addresses their unique needs.
Analysts currently set an average price target of 12.86 USD for the LifeStance Health Group stock (median: 13.00 USD), implying +4.3 % versus the latest price. The consensus is based on 18 analyst ratings.
18 analysts currently rate the LifeStance Health Group stock: 14 recommend buying, 4 holding and 0 selling. For 2026, analysts expect LifeStance Health Group to generate revenue of 1.71 B USD and earnings per share of 0.16 USD.
Converted at the current exchange rate, the LifeStance Health Group share trades at 11.01 EUR (12.34 USD).
The LifeStance Health Group share (LFST) is listed on 1 stock exchanges, including: NASDAQ (LFST).
Lifestance Health Group Inc is a leading provider of behavioral health services in the United States. The company was founded to make mental health services more accessible to a wider audience by developing innovative solutions tailored to the individual needs and requirements of each patient. Lifestance Health Group offers holistic mental health services provided by experienced and qualified professionals. These services include psychological counseling, psychotherapy, psychiatry, neuropsychology, and clinical social work. The company also offers telehealth services that allow customers to virtually connect with their healthcare providers, as well as specialized programs for children, adolescents, and families. The company operates in three main segments: Clinic Segment, Telehealth Services, and Specialized Programs. In summary, Lifestance Health Group offers a comprehensive portfolio of mental health services tailored to the specific needs and requirements of each patient. The company is committed to developing innovative solutions to facilitate access to mental health services and improve people's quality of life.
The expected revenue of LifeStance Health Group is 1.71 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of LifeStance Health Group is 62.79 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of LifeStance Health Group is currently 77.23. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the LifeStance Health Group stock.
The price-to-sales ratio (P/S) of LifeStance Health Group is currently 2.84. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the LifeStance Health Group stock.
The Eulerpool Quality Score for LifeStance Health Group is 4/10.
The ISIN of LifeStance Health Group is US53228F1012. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of LifeStance Health Group is LFST. The ticker symbol is used to trade LifeStance Health Group shares on the stock exchange.
LifeStance Health Group stock
LifeStance Health Group Peer Group
LifeStance Health Group Ticker
LifeStance Health Group FIGI
All fundamentals and in-depth analysis of LifeStance Health Group
Our stock analysis for LifeStance Health Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LifeStance Health Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.